首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles
【2h】

GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles

机译:GnRH拮抗剂用于多囊卵巢综合征患者在接受控制性过度刺激的卵巢中​​进行新鲜周期的体外受精和胚胎移植

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present study was to evaluate the influence of a gonadotropin-releasing hormone (GnRH) antagonist compared with a GnRH agonist on the in vitro fertilization cycle outcome in patients with polycystic ovary syndrome. The outcomes of pregnancy were evaluated. The area under the curve (AUC) of the receiver operating characteristic (ROC) curve was also used to evaluate whether the endometrial thickness (cm) and estradiol (E2) level (pg/ml) on the day of human chorionic gonadotropin (hCG) administration (the hCG day) had the best sensitivity and specificity for predicting a clinical pregnancy. The results demonstrated that there were significant differences in the E2 and progesterone levels between the two treatment groups on the hCG day. Furthermore, the mean number of total oocytes retrieved, mean number of 2 pronuclei oocytes, mean number of oocytes cleaved (P<0.05), mean number of embryos available (P=0.022) and mean number of embryos transferred (P=0.014) were significantly different. Additionally, the rates of ectopic pregnancy (P=0.984) and ovarian hyperstimulation syndrome (P=0.976) did not differ significantly between the treatment groups. Although the biochemical pregnancy (P=0.592), clinical pregnancy (P=0.617) and live birth (P=0.365) rates were lower with the GnRH antagonist than with the GnRH agonist, there were no significant differences in the outcomes between the two groups. Analysis of the influence of endometrial thickness with respect to the clinical pregnancy using the ROC (AUC) method revealed that when the best cutoff of 9.75 cm was used, the sensitivity was 62.5%, the specificity was 43.1% and the AUC was 0.53. Additionally, the Youden index was 0.056. Analysis of the influence of the E2 level on the hCG day on clinical pregnancy, using the ROC (AUC) method showed that the best cutoff was 2,984.5 pg/ml, which had a sensitivity of 68.8% and specificity of 52.9%, while the AUC was 0.573 (with a Youden index of 0.217). Furthermore, the results demonstrated that neither the endometrial thickness nor the E2 level on the hCG day had the best sensitivity and specificity for predicting a clinical pregnancy.
机译:本研究的目的是评估促性腺激素释放激素(GnRH)拮抗剂与GnRH激动剂相比对多囊卵巢综合征患者体外受精周期的影响。评估了妊娠结局。受体工作特性(ROC)曲线的曲线下面积(AUC)也用于评估人绒毛膜促性腺激素(hCG)那天的子宫内膜厚度(cm)和雌二醇(E2)水平(pg / ml)注射(hCG日)对预测临床妊娠具有最佳敏感性和特异性。结果表明,在hCG日,两个治疗组之间的E2和孕酮水平存在显着差异。此外,取回的卵母细胞总数的平均值,2个原核卵母细胞的平均值,卵裂的平均卵数(P <0.05),可利用的胚胎平均数(P = 0.022)和转移的胚胎平均数(P = 0.014)为明显不同。此外,治疗组之间的异位妊娠率(P = 0.984)和卵巢过度刺激综合征(P = 0.976)没有显着差异。尽管GnRH拮抗剂的生化妊娠率(P = 0.592),临床妊娠率(P = 0.617)和活产率(P = 0.365)均低于GnRH激动剂,但两组的预后没有显着差异。使用ROC(AUC)方法分析子宫内膜厚度对临床妊娠的影响,发现当使用9.75 cm的最佳截止值时,敏感性为62.5%,特异性为43.1%,AUC为0.53。另外,Youden指数为0.056。使用ROC(AUC)方法分析E2水平对hCG日对临床妊娠的影响,结果显示最佳截止值为2,984.5 pg / ml,灵敏度为68.8%,特异性为52.9%,而AUC为0.573(尤登指数为0.217)。此外,结果表明,hCG日子宫内膜厚度和E2水平都不具有预测临床妊娠的最佳敏感性和特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号